83
Participants
Start Date
August 31, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
April 30, 2018
Endurance Exercise Training
Three months of supervised training. Interval training, 3 sessions weekly of 45 min. During intervals the intensity will be minimum 70 % of VO2 max
Resistance Exercise Training
Three months of supervised resistance training. Subjects will perform 3 weekly sessions of 45 min. The intensity will be kept at minimum 60% of 1RM.
No Exercise
Control to exercise
Tocilizumab
Tocilizumab infusion will be administered monthly (8 mg/kg body weight i.v., maximun 800 mg). Each subject will receive 3 infusions during the study period.
Placebo
Saline infusion will be administered monthly (same volume as Tocilizumab). Each subject will receive 3 infusions during the study period.
Rigshospitalet, Centre of Inflammation and Metabolism (CIM) Centre for Physical Activity Research (CFAS), Copenhagen
Rigshospitalet, Denmark
OTHER